home / stock / asnd / asnd short
Short Information | Ascendis Pharma A/S (NASDAQ:ASND)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,070,958 |
Total Actual Volume | 5,654,386 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 53,548 |
Average Short Percentage | 18.97% |
Is there a ASND Short Squeeze or Breakout about to happen?
See the ASND Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $134.28 | $136.27 | $137.58 | $133.82 | 245,407 | 39,749 | 16.2% |
07-01-2024 | $135.68 | $133.98 | $138.11 | $132.27 | 215,438 | 49,603 | 23.02% |
06-28-2024 | $136.11 | $136.38 | $137.735 | $133 | 260,115 | 52,234 | 20.08% |
06-27-2024 | $132.5 | $135.4 | $136.65 | $132.26 | 200,506 | 34,491 | 17.2% |
06-26-2024 | $135.69 | $132.65 | $135.79 | $131.5 | 199,199 | 34,928 | 17.53% |
06-25-2024 | $134.47 | $135.79 | $138.75 | $133.45 | 629,131 | 145,621 | 23.15% |
06-24-2024 | $129.02 | $129.39 | $130.14 | $126.37 | 362,623 | 73,045 | 20.14% |
06-21-2024 | $122.18 | $127.85 | $128.27 | $121.36 | 322,272 | 66,370 | 20.59% |
06-20-2024 | $123.22 | $121.62 | $123.4 | $121.07 | 234,132 | 56,726 | 24.23% |
06-18-2024 | $125.1 | $123.19 | $125.72 | $123.19 | 305,805 | 134,971 | 44.14% |
06-17-2024 | $127.64 | $124.59 | $128.97 | $123.04 | 295,890 | 34,500 | 11.66% |
06-14-2024 | $126.36 | $127.64 | $128.649 | $124.58 | 209,012 | 24,213 | 11.58% |
06-13-2024 | $131.53 | $127.84 | $132.08 | $127.58 | 261,627 | 64,229 | 24.55% |
06-12-2024 | $132.37 | $131.27 | $134.015 | $124.9 | 680,284 | 61,745 | 9.08% |
06-11-2024 | $131.44 | $131.93 | $134.91 | $130.28 | 209,872 | 24,111 | 11.49% |
06-10-2024 | $136.87 | $131.48 | $138.38 | $131.25 | 238,417 | 22,529 | 9.45% |
06-07-2024 | $138.18 | $137.17 | $138.81 | $133.754 | 131,277 | 20,847 | 15.88% |
06-06-2024 | $138.58 | $138.5 | $139.42 | $135.605 | 163,349 | 28,977 | 17.74% |
06-05-2024 | $135.66 | $138.5 | $140.09 | $134.2 | 250,835 | 51,616 | 20.58% |
06-04-2024 | $135.12 | $134.46 | $136.065 | $133.11 | 239,195 | 50,453 | 21.09% |
News, Short Squeeze, Breakout and More Instantly...
• Data demonstrate significant improvements in well-being and physical functioning compared to placebo in patients treated for 1 year with TransCon CNP at the pivotal 100μg/kg/week dose • Improvements could not be explained by changes in linear growth only, supporti...
2024-06-19 21:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
COPENHAGEN, Denmark, June 04, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024, at 8:00 a.m. ET in Miami, Florida. A...